Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recormon for Anemia in Malignant Tumors
NCT02624141Phase 4Terminated
- Sponsor
- Roche
- Start
- Apr 2006
- Primary completion
- Dec 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin beta in anemia, sponsored by Roche. Started Apr 2006; status: terminated.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02624141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624141.